Second, using bidirectional MR), we sought to determine whether blood levels of SMOC1 were causally influenced by NAFLD, obesity or glycemic traits and if SMOC1 could be causally implicated in the etiology of metabolic traits and metabolic diseases such as NAFLD and T2D. This evidence concerns the gene SMOC1 and metabolic dysfunction-associated steatotic liver disease.